Results 91 to 100 of about 9,325 (168)

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles

Cancer Management and Research, 2020
Yuxin Zhong,1 Jing Zhang,2 Xiaofeng Bai,1 Yuemin Sun,1 Hao Liu,1 Shuai Ma,1 Yang Li,1 Wenzhe Kang,1 Fuhai Ma,1 Weikun Li,1 Yantao Tian1 1Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer ...
Zhong Y, Zhang J, Bai X, Sun Y, Liu H, Ma S, Li Y, Kang W, Ma F, Li W, Tian Y   +10 more
doaj  

Evaluation of the feasibility, safety, and preliminary effectiveness of hyperthermic intraperitoneal chemotherapy following radical surgery for locally advanced gastric cancer

Frontiers in Oncology
ObjectiveTo explore the feasibility, safety, and potential association between hyperthermic intraperitoneal chemotherapy (HIPEC) and peritoneal recurrence in patients with locally advanced gastric cancer following D2 radical surgery.Materials and ...
Tianze Zhang, Hang Yu, Lang Wang, Shijun Zhao, Cheng Zhao, Jie Chai, Dehai Wang   +6 more
doaj   +1 more source

Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

World Journal of Surgical Oncology
Background Small bowel obstruction (SBO) affects ~ 30% of ovarian cancer (OC) patients, leading to readmission, debilitating symptoms, and death within one year. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) effectively
Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, Felipe Lopez-Ramirez, Vladislav Kovalik, Sergei Iugai, Teresa Diaz-Montes, Vadim Gushchin   +7 more
doaj   +1 more source

Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.

PLoS ONE
Standard treatment for patient with peritoneal metastases from colorectal cancer is cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). In recent years, the efficacy of oxaliplatin-based HIPEC has been challenged.
Lana Ghanipour, Gabriella Jansson Palmer, Per J Nilsson, Caroline Nordenvall, Jan-Erik Frödin, Elinor Bexe Lindskog, Dan Asplund, Torbjörn Swartling, Wilhelm Graf, Helgi Birgisson, Ingvar Syk, Victor Verwaal, Jenny Brändstedt, Peter H Cashin   +13 more
doaj   +1 more source

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC

, 2010
Bolnik s peritonealno karcinozo, zdravljen s sistemsko kemoterapijo, ima slabo napoved in preživetje nekaj mesecev. V zadnjih letih je postala hipertermična intraperitonealna kemoterapija (HIPEC) po popolni kirurški odstranitvi tumorja možen način ...
Barbka Novak
core  

Construction of sensitive quality index system of perioperative nursing during hyperthermic intraperitoneal chemotherapy

Huli yanjiu
ObjectiveTo construct a sensitive quality indicators system for hyperthermic intraperitoneal chemotherapy（HIPEC），and provide a scientific tool for improving nursing quality.MethodsBased on the theoretical basis of "structure⁃process⁃outcome" quality ...
XIAO Xueying, HUANG Yulin, LI Yanmei, WANG Haoyun   +3 more
doaj  

Determination of biochemical indicators when modeling HIPEC with cisplatin on rats [PDF]

, 2019
HIPEC (Hyperthermic intraperitoneal chemotherapy; hyperthermic intraoperative intraperitoneally chemoperfusion) is a method of treating primary and secondary peritoneal tumors.
Tretyakov, A. M., Pykhtieieva, E. G., Gozhenko, A. I., Pykhtieieva, E. D.   +3 more
core  

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

Minimally Invasive Versus Open CRS/HIPEC for Peritoneal Surface Malignancies: Postoperative Recovery and Long-Term Outcomes-A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Aulicino M, Tondolo V, Abatini C, D'Annibale G, Barberis L, Saiz M, Fiorillo C, De Sio D, Quero G, Alfieri S, Pacelli F, Santullo F.   +11 more
europepmc   +1 more source

Perioperative Fluid Management and Renal Protection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Scoping Review. [PDF]

J Clin Med
Pasta G, L'Acqua C, Filetici N, Bernardi G, Cuomo A, De Robertis E, Bove T, Simonte R, Frassanito L.   +8 more
europepmc   +1 more source